Technology License Agreement Sample Contracts

Technology License Agreement • April 26th, 2010 • Fairway Properties, Inc. • Services-computer programming, data processing, etc.

Get the Official Word Add-in

THIS TECHNOLOGY LICENSE AGREEMENT (the “Agreement”) is made and entered into this 8TH day of December, 2009, by and between SenCer Inc., a New York corporation (“Licensor”), and GreenCell, Incorporated, a to be formed Florida Corporation (the “Company”).

Technology License Agreement • May 25th, 2005 • Compuprint Inc • Miscellaneous manufacturing industries • New York

Technology License Agreement • June 8th, 2006 • Photronics Inc • Semiconductors & related devices • Delaware

Technology License Agreement • December 28th, 2011 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • Minnesota

THIS TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made effective as of March 19, 2008 (the “Effective Date”) and entered into by and between Surgi-Vision, Inc., a Delaware corporation (“SVI”), and Cardiac Pacemakers, Inc. (“CPI”) (individually, a “Party” and collectively, the “Parties”).

THIS NMAP TECHNOLOGY LICENSE AGREEMENT (together with all exhibits and other attachments hereto, the "Agreement") is entered into and effective as of the last signature date set forth below, or 14 days after the first signature on the fully executed contract, whichever is earlier (“Effective Date”), by and between (“Licensee”), and Insecure.Com, LLC, a California company located at 113 Cherry St #1337, Seattle, WA 98104-2205 (“Insecure”).

Technology License Agreement • March 2nd, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario

INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Technology License Agreement • March 30th, 1998 • Spiros Development Corp Ii Inc • Pharmaceutical preparations • California

Technology License Agreement • August 31st, 2009 • Neptune Technologies & Bioressources Inc. • Quebec

This TECHNOLOGY LICENSE AGREEMENT (the “Agreement”) entered into this 15th day of October, 2008 (the “Effective Date”) by and between Neptune Technologies & Bioressources Inc. (“Licensor”) and Neuro Vimer Pharm Inc. renamed NeuroBioPharm Inc. (the “Company”) (Licensor and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”). Agreement reviewed the 20 February 2009.

Technology License Agreement • April 10th, 2013 • BioAmber Inc. • Industrial organic chemicals • Delaware

This Agreement (the “Agreement”), made and effective as of the Effective Date, by and between Celexion, LLC, a Delaware limited liability company having its principal place of business at One Memorial Drive, Suite 7, Cambridge, MA 02142 (hereinafter referred to as “Celexion” or “Licensor”) and DNP Green Technology, Inc., a Delaware corporation having its principal place of business at 1250 Rene-Levesque West, Suite 4110, Montreal, QC, Canada, H3B 4W8 (hereinafter referred to as “DNP Green” or “Licensee”).

Technology License Agreement • June 28th, 2002 • Tvia Inc • Semiconductors & related devices • California

Technology License Agreement • March 10th, 2008 • Sonics, Inc. • Semiconductors & related devices • California

This Patent and Technology License Agreement (“Agreement”) is by and between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas M. D. Anderson Cancer Center (“MD Anderson”), a member institution of System, and [Company name], a [jurisdiction] [corporation/LLC/etc.], with its principal place of business at _____________ (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Technology License Agreement • August 30th, 2000 • Curon Medical Inc • Electromedical & electrotherapeutic apparatus • California

[*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

Technology License Agreement • April 10th, 2013 • BioAmber Inc. • Industrial organic chemicals • Delaware

This Technology License Agreement (hereinafter “Agreement”) dated February 15th, 2012 (the “Effective Date”) is by and among Sinoven Biopolymers, Inc., a corporation duly organized and existing under the laws of the State of Delaware, having its principal place of business in Malvern, Pennsylvania (hereinafter called “Sinoven”); NatureWorks LLC, a limited liability company organized and existing under the laws of the State of Delaware, having its principal place of business in Minnetonka, Minnesota (hereinafter called “NatureWorks”); AmberWorks LLC, a limited liability company duly organized and existing under the laws of the State of Delaware, having its principal place of business in Plymouth, Minnesota (hereinafter called “LLC”), and BioAmber, Inc. a corporation duly organized and existing under the laws of the State of Delaware (hereinafter called “BioAmber”).

Technology License Agreement • July 7th, 2011 • China Ming Yang Wind Power Group LTD • Engines & turbines

In this Contract, Party B transfers the use right of technological know-how of 1.5MW wind turbine design and manufacturing technology and engineering service technology to Party A and Party A shall pay relevant charges. The following agreement is hereby concluded between and abided by the two parties through consultation on the basis of equality and truly and sufficiently expressing their will according to “Contract Law of the People’s Republic of China”.

This Addendum is attached to and forms part of the Technology License Agreement by and between Lantern Pharmaceuticals Inc., a Texas corporation (hereinafter referred to as “LANTERN”) having principal offices at 4287 Beltline Rd., Suite #270, Addison, TX 75001 and AF Chemicals, LLC, a Californian Limited Liability Company having principal offices at 5545 Coral Reef, La Jolla, CA 92037 (hereinafter referred to as “AFC”) as of February 8, 2016 (the “EFFECTIVE DATE”) (hereinafter the “LANTERN AFC ADDENDUM”). LANTERN and AFC are sometimes each individually referred to hereinafter as a “Party” and collectively referred to hereinafter as the “Parties”. To the extent that any of the terms or conditions contained in this LANTERN AFC ADDENDUM may contradict or conflict with any of the terms or conditions of the Technology License Agreement dated January 15, 2015, it is expressly understood and agreed that the terms of this LANTERN AFC ADDENDUM shall take precedence and supersede the Technology